Statistics

Most searched data by different categories

Animal

Colostrum 93.5%

Oleum morrhuae 6.5%

ATC Classification

Paracetamol (N02BE01) 0.7%

Omeprazole (A02BC01) 0.7%

Azithromycin (J01FA10) 0.7%

Amoxicillin (J01CA04) 0.7%

Sildenafil (G04BE03) 0.6%

Metformin (A10BA02) 0.6%

Fluconazole (D01AC15) 0.6%

Amlodipine (C08CA01) 0.5%

Ciprofloxacin (J01MA02) 0.5%

Pantoprazole (A02BC02) 0.5%

Tadalafil (G04BE08) 0.4%

Cetirizine (R06AE07) 0.4%

Diclofenac (D11AX18) 0.4%

Ambroxol (R05CB06) 0.4%

Albendazole (P02CA03) 0.4%

Rabeprazole (A02BC04) 0.4%

Atorvastatin (C10AA05) 0.3%

Lansoprazole (A02BC03) 0.3%

Cefixime (J01DD08) 0.3%

Clopidogrel (B01AC04) 0.3%

Loratadine (R06AX13) 0.3%

CAS Number

40949-94-8 0.7%

160970-54-7 0.2%

144060-53-7 0.2%

147098-20-2 0.1%

202138-50-9 0.1%

89-57-6 0.1%

217087-09-7 0.1%

220127-57-1 0.1%

57808-66-9 0.1%

154229-19-3 0.1%

668270-12-0 0.1%

128-13-2 0.1%

111470-99-6 0.1%

58-93-5 0.1%

129938-20-1 0.1%

148553-50-8 0.1%

461432-26-8 0.1%

503612-47-3 0.1%

104344-23-2 0.1%

171599-83-0 0.1%

492-62-6 0.1%

Manufacturer

Marcyrl Pharmaceuticals 0.5%

ACULIFE HEALTHCARE PRIVATE LIMITED 0.4%

Helba İlaç İç ve Dış San. Tic. Ltd.. 0.4%

YooYoung Pharmaceutical Co Ltd 0.3%

Hainan Haiyao Co., Ltd. 0.3%

Lok-Beta Pharmaceuticals (I) PVT. LTD. 0.3%

Elko Organization Ltd SA 0.3%

SP Accure Labs Pvt Ltd 0.3%

China Resources Zizhu 0.3%

Abdi Ibrahim Ilac San. ve Tic. A.S. 0.3%

Panpharma S.A 0.3%

Fitofarm 0.3%

Shandong Luoxin Pharmaceutical Group Co... 0.3%

Luoxin Biotechnology(Shanghai)Co. , .. 0.3%

VHB Medi Sciences Limited 0.3%

Ahngook Pharmaceutical 0.3%

Cristalia Produtos Quimicos Farma Ltda 0.3%

Lyra Laboratories PVT. LTD. 0.3%

Krewel Meuselbach Gmbh 0.3%

Noro Bio-Pharmaceutical Co Ltd 0.3%

GALENTIC PHARMA (INDIA) PVT LTD 0.3%

Continent

Europe 37.7%

Asia 28.7%

Africa 13.9%

Australia 2.5%

South America 2.5%

North America 0.8%

Country

China 35.2%

India 26.2%

Turkey 3.4%

Italy 3.1%

Korea, South 2.4%

Germany 2.4%

USA 2.3%

Switzerland 2.3%

Spain 2.3%

Brazil 2%

Egypt 1.6%

Greece 1.5%

Poland 1.5%

France 1.3%

United Kingdom 1.1%

Morocco 0.9%

Belgium 0.8%

Malaysia 0.7%

Netherlands 0.7%

Portugal 0.5%

Ukraine 0.5%

Herbal

Ginkgo biloba 15.4%

Aesculus hippocastanum, Ruscus aculeatus.. 6.6%

Eucalyptus sp. 5%

Hedera helix 3.2%

Rosmarinus officinalis 2.9%

Salvia officinalis 2.8%

Trigonella foenum-graecum, Sauropus spat.. 2.7%

Lavandula angustifolia 2.6%

Frangula purshiana (syn. Cascara sagrada.. 2.5%

Eucalyptus globulus 2.4%

Citrus sinensis 2.2%

Euphrasia rostkoviana, Vaccinium myrtill.. 2.2%

Thymus vulgaris 2.1%

Vaccinium myrtillus, Vitis vinifera 2.1%

Melaleuca alternifolia 2.1%

Ocimum americanum (syn. O. canum) 2%

Citrus reticulata (syn. C. nobilis) 2%

Pinus sylvestris 1.9%

Citrus limon (syn. C. limonum) 1.9%

Epimedium grandiflorum, Lepidium meyenii 1.9%

Cinnamomum aromaticum 1.9%

Content Type

Monocomponent 57.5%

Policomponent 42.5%

Product Type

Finished Product 27.3%

API 18.2%

Food Supplement 14.7%

Medical device 14.1%

Dossier 9.5%

Substances, chemicals 8.3%

Packaging materials 7.7%

GMP (local) 10.9%

GMP (FDA) 10.5%

GMP (EU) 10.5%

GMP (WHO) 6.4%

GACP 4.5%

ISO 9001 4.5%

ISO 22000 4.1%

ISO 11607 3.8%

ISO 14987 3.8%

ASTM D1585 3.8%

ASTM F2097 3.8%

EN 868 3.8%

GLP 3.8%

GDP 3.8%

ISO 22 001 3.8%

ISO 14 001 3.8%

ISO 13485 3.8%

ISO 18 001 3.8%

HACCP 3.8%

BIQS-Singapore 3.4%

Status

Distributor 47.8%

Manufacturer 27.8%

Agent 13.9%

Manager 10.4%